HERON THERAPEUTICS INCHERON THERAPEUTICS INCHERON THERAPEUTICS INC

HERON THERAPEUTICS INC

No trades
See on Supercharts

Price target

5.960.000.00%
The 4 analysts offering 1 year price forecasts for AXD2 have a max estimate of — and a min estimate of —.

Analyst rating

Based on 4 analysts giving stock ratings to AXD2 in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


AXD2 EPS for the last quarter is 0.02 EUR despite the estimation of −0.03 EUR. In the next quarter EPS is expected to reach −0.01 EUR. Track more of HERON THERAPEUTICS INC financials and stay on top of what is up with the company.
In the next quarter HERON THERAPEUTICS INC revenue is expected to reach ‪34.39 M‬ EUR. Check out HERON THERAPEUTICS INC revenue and earnings and make informed decisions.
According to analysts, AXD2 price target is 5.96 EUR with a max estimate of 8.58 EUR and a min estimate of 3.81 EUR. Check if this forecast comes true in a year, meanwhile watch HERON THERAPEUTICS INC stock price chart and keep track of the current situation with AXD2 news and stock market news.